Exact Sciences' shareholders have re-elected three members of its board of directors, including company President and CEO Kevin Conroy, as well as Katherine Napier, and David Thompson.
Napier, who has been a director since 2009, spent over two decades at Procter and Gamble, where she was a GM of the firm's North American pharmaceutical business.
Thompson, who spent 30 years at Abbott Laboratories and served as VP and president of Abbott's Laboratories Diagnostics Division, has been a director at Exact Sciences since 2010.
Proteomics International announced this week that it has appointed Roopwant Judge to a business development role with the company.